MENU
+Compare
AORT
Stock ticker: NYSE
AS OF
Apr 3, 01:18 PM (EDT)
Price
$24.31
Change
-$0.74 (-2.95%)
Capitalization
873.56M

AORT Artivion Forecast, Technical & Fundamental Analysis

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions... Show more

AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for AORT with price predictions
Apr 02, 2025

AORT's RSI Indicator recovers from oversold territory

The RSI Indicator for AORT moved out of oversold territory on March 18, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 23 similar instances when the indicator left oversold territory. In of the 23 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on March 21, 2025. You may want to consider a long position or call options on AORT as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AORT just turned positive on March 18, 2025. Looking at past instances where AORT's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AORT advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AORT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AORT entered a downward trend on March 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.100) is normal, around the industry mean (23.715). AORT has a moderately high P/E Ratio (434.783) as compared to the industry average of (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.439) is also within normal values, averaging (41.612).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AORT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

AORT is expected to report earnings to fall 100.08% to 0 cents per share on May 01

Artivion AORT Stock Earnings Reports
Q1'25
Est.
$0.00
Q4'24
Missed
by $0.33
Q3'24
Beat
by $0.18
Q2'24
Beat
by $0.16
Q1'24
Beat
by $0.18
The last earnings report on February 24 showed earnings per share of -38 cents, missing the estimate of -5 cents. With 27.00K shares outstanding, the current market capitalization sits at 873.56M.
A.I.Advisor
published Dividends

AORT paid dividends on December 18, 2015

Artivion AORT Stock Dividends
А dividend of $0.03 per share was paid with a record date of December 18, 2015, and an ex-dividend date of December 09, 2015. Read more...
A.I. Advisor
published General Information

General Information

a provider of cryopreserved human tissue for vascular transplant applications

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1655 Roberts Boulevard North West
Phone
+1 770 419-3355
Employees
1500
Web
https://www.artivion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANDRX15.000.03
+0.20%
AQR International Defensive Style R6
SIDNX10.98N/A
N/A
Hartford Schroders Intl Multi-Cp Val I
PUGCX13.68N/A
N/A
Putnam Focused International Equity C
FBLEX13.60N/A
N/A
Fidelity Series Stk Selec Lg Cp Val
GTAPX13.49-0.02
-0.15%
Glenmede Long/Short Eq Ptf

AORT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with BSX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
+1.54%
BSX - AORT
43%
Loosely correlated
-1.18%
SONVY - AORT
42%
Loosely correlated
-1.31%
SIBN - AORT
41%
Loosely correlated
+2.28%
GKOS - AORT
41%
Loosely correlated
+3.04%
ITGR - AORT
40%
Loosely correlated
+2.13%
More